Promoting Clinical Trial Informativeness in Africa
Overview
This policy briefing synthesizes key insights from the Cameroon Townhall for Healthcare Professionals meeting held on December 16, 2023, focusing on the theme "Promoting Clinical Trial Informativeness in Africa: The Role of DAC-Africa."
Context
The 90th edition of the Cameroon Town Hall celebrated the year's achievements in healthcare discussions and policies. Participant reflections highlighted the impact of these sessions on healthcare practices.
Key issues
- Clinical Trial Informativeness. Promote more informative clinical trials in Africa.
- Challenges of Uninformative Trials. Many trials, particularly in Africa, fail to yield results that significantly impact patient care or policy formulation.
- Role of DAC-Africa. A Bill & Melinda Gates Foundation-funded three-year pilot program aimed to enhance the quality and informativeness of clinical trials in Africa, focusing on Design, Analyze, and Communicate, to improve clinical trial quality, building infrastructure and increasing investments, supported by Africa CDC. https://dac-trials.tghn.org/
Discussion highlights
- Urgency in improving clinical trial informativeness in Africa.
- The role of ethical and effective research practices in enhancing trial quality.
- Prospects for growth in clinical research and the importance of collaborative efforts.
Recommendations
- Raising Awareness. Enhance understanding of the importance of clinical trial informativeness among researchers and healthcare professionals.
- Protocol Review. Encourage Principal Investigators to submit protocols to DAC-Africa for review and optimize their protocol design.
- Knowledge Dissemination. Share insights from this session with broader healthcare communities to foster information on the services of DAC-Africa.
Next steps
Follow-up meeting scheduled for January 13, 2024, with details to be confirmed.
Conclusion
The session underscored the critical need for more informative clinical trials in Africa to improve health outcomes. Stakeholder engagement and concerted efforts in initiatives like DAC-Africa are essential to achieving this goal.
Meeting minutes
Agenda
- Welcome and Opening Remarks by the Chair, Dr. Munoh Kenne Foma
- Participant Reflections
- Presentation by Elvis Ndansi on "Promoting Clinical Trial Informativeness in Africa: The Role of DAC-Africa"
- Discussion and Q&A
- Adjournment, Closing points and Next Meeting
- Parking Lot Discussions
Opening remarks
- The meeting celebrated the 90th edition of the Cameroon Town Hall.
- Reflections on the year's achievements, including discussions on various healthcare topics and guest speakers like the Cameroon Minister of Health.
- Attendees shared their experiences and learnings from the past year's town hall sessions, emphasizing the importance of these discussions in shaping healthcare policies and practices.
Presentation
1. Clinical Trial Informativeness
The concept of 'informativeness' in clinical trials was emphasized, highlighting the importance of trials that provide meaningful results for patients, clinicians, researchers, and policymakers.
2. Challenges of Uninformative Trials
A significant number of clinical trials, both globally and in Africa, are uninformative, meaning they fail to provide results that can meaningfully influence patient care, clinical practices, or policymaking.
3. Statistics on Clinical Trials
Between 2009 and 2010, only a small percentage of assessed clinical trials were considered informative. Africa, despite bearing a significant portion of the global disease burden, hosts only a small fraction of clinical trials.
4. Role of DAC-Africa
DAC-Africa focuses on Design, Analyze, and Communicate, crucial elements in conducting clinical trials. DAC-Africa, a Bill & Melinda Gates Foundation-funded three-year program, aimed to enhance the quality and informativeness of clinical trials in Africa. It provides specialized protocol review services for Principal Investigators and funders of clinical trials in Africa, and extends trial planning grants of up to $30,000. Discussion covered building clinical trial infrastructure and increasing investments in Africa, including efforts by Africa CDC. https://dac-trials.tghn.org/
5. Importance of Ethical and Effective Research
The need for ethical and effective research practices in Africa was highlighted, especially in the context of increasing clinical trial infrastructure and investment.
6. Prospects, Engagement and Collaboration
The presentation looked forward to the growth of clinical research in Africa, emphasizing the need for more informative trials to improve health outcomes. The session encouraged increased awareness and participation in initiatives like DAC-Africa.
Discussion and Q&A
- Interactive Q&A. Participants discussed various aspects of clinical trials and research in Africa, with emphasis on the need for informative trials to improve health outcomes.
Calls to action and closing
- Increase awareness and understanding of clinical trial informativeness.
- Encourage participation in DAC-Africa's initiatives to improve clinical trial quality.
- Share knowledge and insights from the session with broader healthcare communities. DAC-Africa: https://dac-trials.tghn.org/
- Adjournment and closing remarks by Dr. Munoh Kenne Foma.
Next meeting
January 13, 2024. Details to be confirmed.
Submitted by the Co-Moderators, Cameroon Town Hall for Healthcare Professionals.
